tm logo
ULTRAVERSE INDEX OLIGOS
Live/Registered
REGISTERED

on 13 Jun 2023

Last Applicant/ Owned by

Serial Number

79345728 filed on 14th Jun 2022

Registration Number

7077701 registered on 13th Jun 2023

in the Principal Register

Correspondent Address

Paulo A. de Almeida

Paulo A. de Almeida

16830 Ventura Blvd., Suite 360

Encino CA 91436

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ULTRAVERSE INDEX OLIGOS

Kits composed of reagents for genetic testing for medical and scientific research purposes; nucleic acid-based kits and reagents for genetic testing for medical and scientific research purposes Reagents for medical use; diagnostic reagents for medicinal use; reagents for use in medical genetic testing; medical diagnostic reagents; nucleic acid sequences for medical purposes

Classification Information


Class [005]
Pharmaceutical Products


Reagents for medical use; diagnostic reagents for medicinal use; reagents for use in medical genetic testing; medical diagnostic reagents; nucleic acid sequences for medical purposes

Class [001]
Chemical Products


Kits composed of reagents for genetic testing for medical and scientific research purposes; nucleic acid-based kits and reagents for genetic testing for medical and scientific research purposes

Mark Details


Serial Number

No 79345728

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Mar 2024NEW REPRESENTATIVE AT IB RECEIVED
28th Jan 2024NEW REPRESENTATIVE AT IB RECEIVED
30th Dec 2023NEW REPRESENTATIVE AT IB RECEIVED
10th Oct 2023FINAL DECISION TRANSACTION PROCESSED BY IB
18th Sep 2023FINAL DISPOSITION PROCESSED
18th Sep 2023FINAL DISPOSITION NOTICE SENT TO IB
13th Sep 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13th Jun 2023REGISTERED-PRINCIPAL REGISTER
13th Jun 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
28th Mar 2023PUBLISHED FOR OPPOSITION